Inactive Instrument
Isodiol International Inc Stock Canadian Securities Exchange
Stocks
CA46500L1013
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.91M 2.82M 2.43M 2.3M 2.08M 269M 3.93M 27.32M 10.51M 137M 10.59M 10.36M 433M | P/E 2018 |
-4.94x | P/E 2019 | -0.37x |
|---|---|---|---|---|---|
| Enterprise Value | 9.13M 6.58M 5.67M 5.37M 4.87M 629M 9.18M 63.79M 24.53M 320M 24.73M 24.18M 1.01B | EV / Sales 2018 |
12.6x | EV / Sales 2019 | 2.48x |
| Free-Float |
100% | Yield 2018 * |
-
| Yield 2019 | - |
| 1 day | -3.58% |
| Manager | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 2017-05-23 |
Andrew Alvis
DFI | Director of Finance/CFO | - | - |
| Corporate Officer/Principal | - | 2018-08-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Marcos Agramont
BRD | Director/Board Member | - | 2017-05-23 |
| Director/Board Member | - | 2018-08-29 | |
| Director/Board Member | - | 2018-11-20 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.58% | +881.08% | - | - | 128 | |
| 0.00% | -1.22% | -14.56% | -5.64% | 13.4B | |
| -1.27% | -3.07% | -33.48% | -56.88% | 4.78B | |
| -0.61% | -5.58% | -5.83% | -6.20% | 4.36B | |
| -1.49% | -4.28% | -11.69% | -32.46% | 3.78B | |
| -1.37% | -3.98% | -25.66% | +0.79% | 3.43B | |
| -2.78% | -3.65% | -4.32% | -5.13% | 3.41B | |
| -0.85% | -4.82% | -13.72% | +3.39% | 3.12B | |
| -1.30% | -2.63% | -24.61% | -18.99% | 2.27B | |
| -2.13% | -2.81% | -29.80% | -20.08% | 1.63B | |
| Average | -1.54% | -2.87% | -18.19% | -15.69% | 4.47B | |
| Weighted average by Cap. | -0.94% | -2.27% | -16.80% | -14.37% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 19.14M 13.79M 11.89M 11.25M 10.2M 1.32B 19.23M 134M 51.4M 670M 51.81M 50.67M 2.12B | 22.25M 16.04M 13.82M 13.08M 11.86M 1.53B 22.36M 155M 59.76M 779M 60.23M 58.91M 2.46B |
| Net income | -36.02M -25.97M -22.37M -21.18M -19.2M -2.48B -36.2M -252M -96.75M -1.26B -97.52M -95.38M -3.99B | -126M -90.76M -78.2M -74.05M -67.12M -8.67B -127M -879M -338M -4.41B -341M -333M -13.94B |
| Net Debt | -15.55M -11.21M -9.66M -9.14M -8.29M -1.07B -15.63M -109M -41.76M -545M -42.1M -41.17M -1.72B | 5.22M 3.76M 3.24M 3.07M 2.78M 360M 5.25M 36.47M 14.03M 183M 14.14M 13.83M 578M |
Employees
-
Sector
Pharmaceuticals
